Plus Therapeutics Inc (PSTV) — Capital Reinvestment Ratio

Latest as of December 2019: 0.06x

Plus Therapeutics Inc (PSTV) has a Capital Reinvestment Ratio of 0.06x as of December 2019, meaning it reinvests 0% of its operating cash flow ($1.04 Million) in capital expenditures ($59.00K). See how leveraged is Plus Therapeutics Inc's balance sheet to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.06x

Capex / Operating Cash Flow

Operating Cash Flow

$1.04 Million

USD

Capital Expenditures

$59.00K

USD

Data as of

Dec 2019

Most recent filing

Annual Capital Reinvestment Ratio for Plus Therapeutics Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Plus Therapeutics Inc from None to None. For live market cap and broader valuation context, see Plus Therapeutics Inc stock valuation.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow